Cannabis is increasingly being used world-wide to treat a variety of dermatological
conditions. Medicinal cannabis is currently legalized in Canada, 31 states in America and 19 …

Background Systemic corticosteroids are often used to treat atopic dermatitis (AD). However,
few studies have assessed the safety and efficacy of systemic corticosteroids in AD …

The therapeutic applications of cannabis and cannabinoids are an increasingly conspicuous
topic as de-criminalization and legalization of these products continues to expand. A limited …

Atopic dermatitis is a common inflammatory skin disorder that afflicts a growing number of
young children. Genetic, immune, and environmental factors interact in a complex fashion to …

Children with chronic atopic dermatitis (AD)‐related itch require a comprehensive treatment
approach that addresses the underlying cause of pruritus, as well as symptoms and …

Introduction: Therapy of atopic dermatitis encloses use of medicated and nonmedicated
preparations. Results of clinical and biophysical procedures indirectly describe the condition …

Importance The use of oral corticosteroids for prolonged periods may be associated with
adverse events (AEs). Nevertheless, the risk of AEs with oral corticosteroids, especially …

Background Atopic dermatitis (AD) is a commonly encountered inflammatory skin disease.
Although acute lesions of acute AD are characterized by intense inflammation, the hallmarks …

Atopic dermatitis is the most common chronic inflammatory skin condition seen in the
pediatric population. In the United States, the prevalence rate of atopic dermatitis is 10 to 12 …

Cannabinoids are compounds found in and derived from the Cannabis plants that have
become increasingly recognised as significant modulating factors of physiological …